Purchases and Sales Made in Q3 2024 in Acadia Pharmaceuticals Inc (ACAD)
This table provides information about the institutional ownership of Acadia Pharmaceuticals Inc (ACAD) during Q3 2024. The information is specifically focused on institutions that hold shares of ACADIA PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Mar 18, 2025
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-343K- 50.4% |
$5.2M - $6.57M
|
338K
$5.76M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-363K- 72.81% |
$5.49M - $6.94M
|
135K
$2.31M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-486K- 74.37% |
$7.36M - $9.31M
|
168K
$2.86M
|
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-686K- 62.05% |
$10.4M - $13.1M
|
419K
$7.16M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-715K- 29.91% |
$10.8M - $13.7M
|
1.68M
$28.6M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-885K- 30.11% |
$13.4M - $16.9M
|
2.05M
$35M
|
|
|
Nov 12, 2024
Q3 2024
|
Jupiter Asset Management LTD
|
SELL
|
- |
-903K- 85.16% |
$13.7M - $17.3M
|
157K
$2.69M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.59M- 57.16% |
$24M - $30.4M
|
1.19M
$20.3M
|